Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ArriVent BioPharma Inc. C...

    NASDAQ: AVBP · Real-Time Price · USD
    23.60
    0.13 (0.55%)
    At close: Jun 06, 2025, 3:59 PM
    22.41
    -5.04%
    After-hours: Jun 06, 2025, 05:03 PM EDT

    ArriVent BioPharma Common Stock Statistics

    Share Statistics

    ArriVent BioPharma Common Stock has 34.21M shares outstanding. The number of shares has increased by 1.56% in one year.

    Shares Outstanding

    n/a
    		 34.21M

    Shares Change (YoY)

    n/a
    		 1.56%

    Shares Change (QoQ)

    n/a
    		 0.95%

    Owned by Institutions (%)

    n/a
    		 82.31%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 14,518

    FTD / Avg. Volume

    n/a
    		 6.1%

    Short Selling Information

    The latest short interest is 5.52M, so 16.14% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.52M

    Short % of Shares Out

    n/a
    		 16.14%

    Short % of Float

    n/a
    		 23.01%

    Short Ratio (days to cover)

    n/a
    		 35.94

    Valuation Ratios

    The PE ratio is -10.42 and the forward PE ratio is -6.88. ArriVent BioPharma Common Stock's PEG ratio is -0.58.

    PE Ratio

    n/a
    		 -10.42

    Forward PE

    n/a
    		 -6.88

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 3.1

    PB Ratio

    n/a
    		 3.25

    P/FCF Ratio

    n/a
    		 -11.94

    PEG Ratio

    n/a
    		 -0.58
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ArriVent BioPharma Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 13.14, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 13.14

    Quick Ratio

    n/a
    		 13.14

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,547,846.15

    Employee Count

    n/a
    		 52

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 28.07% in the last 52 weeks. The beta is 1.27, so ArriVent BioPharma Common Stock's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.27

    52-Week Price Change

    n/a
    		 28.07%

    50-Day Moving Average

    n/a
    		 19.66

    200-Day Moving Average

    n/a
    		 24.83

    Relative Strength Index (RSI)

    n/a
    		 69

    Average Volume (20 Days)

    n/a
    		 237,900

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -94.31M

    Net Income

    n/a
    		 -80.49M

    EBITDA

    n/a
    		 -80.49M

    EBIT

    n/a
    		 -80.49M

    Earnings Per Share (EPS)

    n/a
    		 -2.56
    Full Income Statement

    Balance Sheet

    The company has 74.29M in cash and 176K in debt, giving a net cash position of 74.12M.

    Cash & Cash Equivalents

    n/a
    		 74.29M

    Total Debt

    n/a
    		 176K

    Net Cash

    n/a
    		 74.12M

    Retained Earnings

    n/a
    		 -238.33M

    Total Assets

    n/a
    		 215.5M

    Working Capital

    n/a
    		 172.83M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -70.21M and capital expenditures 0, giving a free cash flow of -70.21M.

    Operating Cash Flow

    n/a
    		 -70.21M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -70.21M

    FCF Per Share

    n/a
    		 -2.23
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    AVBP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for AVBP is $38.5, which is 63.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $38.5

    Price Target Difference

    n/a
    		 63.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 29.63

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist